tailieunhanh - Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?

The aim of this study was to assess and compare the Response Evaluation Criteria in Solid Tumors version (RECIST ) and the Choi criteria in evaluating the early response of advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) treated with sunitinib. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN